Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Birth control pills can help reduce mild to moderate acne in women.

The treatment slowed hair growth but didn't always match the improvements seen by doctors or patients.

Dihydrotestosterone specifically binds to hamster sebaceous glands, with a higher affinity than testosterone.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Certain sex hormones and antiandrogens can either slow down or speed up the growth of human hair follicle cells depending on their concentration.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.